K

Pasithea Therapeutics Corp
D

KTTA

3.05000
USD
-0.04
(-1.29%)
Market Closed
Volume
584
EPS
0
Div Yield
-
P/E
-0
Market Cap
3,862,602
News

Title: Pasithea Therapeutics Corp

Sector: Healthcare
Industry: Biotechnology
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.